{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:07Z","timestamp":1781647027798,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate fibroblast activation protein (FAP)-targeted positron emission tomography and computed tomography (PET\/CT) imaging as surrogate marker for cardiac fibrosis and therefore as prognostic tool for patients with left-sided valvular heart disease undergoing open-heart surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 13 patients (6 men, 7 women; mean age\u2009\u00b1\u2009SD, 62\u2009\u00b1\u200913 years) scheduled for aortic and\/or mitral valve surgery (aortic,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093; mitral,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099; both,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) preoperative FAPi-PET\/CT ([\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-RTX1363S) was perfomred. FAP-positive volume and FAP uptake was quantified by different methods (isocontour with fixed and variable threshold) and correlated to preoperative clinical parameters, including (left ventricular ejection fraction (LVEF) and serum N-terminal prohormone of brain natriuretic peptide (NT-proBNP), as well as to changes in LVEF from preoperatively to 3\u20136 months follow-up (available for\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911 patients). FAP-uptake in the left ventricular (LV) myocardium was highly variable in the study cohort. Isocontour-55%-based FAP-positive volume was found to correlate statistically significantly with preoperative LVEF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) and preoperative NT-proBNP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). In addition, we found a significant correlation with the change in LVEF from preoperatively to 3\u20136 months follow-up examination (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preoperative FAPi PET\/CT seems to have potential to predict LVEF changes after valvular heart surgery and may therefore be an important tool for risk stratification of asymptomatic patients with left-sided valvular heart disease to support the appropriate timing of valvular surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13550-025-01324-5","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:34:33Z","timestamp":1775223273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAPi-PET\/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery"],"prefix":"10.1186","volume":"16","author":[{"given":"Theresa","family":"Holst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgine","family":"Wienand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Pfob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaldas","family":"Girdauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"3","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","volume":"8","author":"B Iung","year":"2011","unstructured":"Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162\u201372.","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"1324_CR2","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60(19):1854\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/CIRCULATIONAHA.104.488825","volume":"112","author":"R Bekeredjian","year":"2005","unstructured":"Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112(1):125\u201334.","journal-title":"Circulation"},{"issue":"5","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/eurheartj\/ehv548","volume":"37","author":"AM Katz","year":"2016","unstructured":"Katz AM, Rolett EL. Heart failure: when form fails to follow function. Eur Heart J. 2016;37(5):449\u201354.","journal-title":"Eur Heart J"},{"issue":"7","key":"1324_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"7","key":"1324_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1053\/j.jvca.2018.11.013","volume":"33","author":"S Seldrum","year":"2019","unstructured":"Seldrum S, de Meester C, Pierard S, Pasquet A, Lazam S, Boulif J, et al. Assessment of left ventricular reverse remodeling by cardiac MRI in patients undergoing repair surgery for severe aortic or mitral regurgitation. J Cardiothorac Vasc Anesth. 2019;33(7):1901\u201311.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"23","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.108.812685","volume":"120","author":"B Villari","year":"2009","unstructured":"Villari B, Sossalla S, Ciampi Q, Petruzziello B, Turina J, Schneider J, et al. Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation. Circulation. 2009;120(23):2386\u201392.","journal-title":"Circulation"},{"issue":"4","key":"1324_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/01.CIR.79.4.744","volume":"79","author":"HP Krayenbuehl","year":"1989","unstructured":"Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. 1989;79(4):744\u201355.","journal-title":"Circulation"},{"issue":"4","key":"1324_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","volume":"56","author":"CF Azevedo","year":"2010","unstructured":"Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56(4):278\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"1324_CR10","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/eurheartj\/ehaa033","volume":"41","author":"M Puls","year":"2020","unstructured":"Puls M, Beuthner BE, Topci R, Vogelgesang A, Bleckmann A, Sitte M, et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J. 2020;41(20):1903\u201314.","journal-title":"Eur Heart J"},{"issue":"4","key":"1324_CR11","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.athoracsur.2016.09.004","volume":"103","author":"T Murashita","year":"2017","unstructured":"Murashita T, Schaff HV, Suri RM, Daly RC, Li Z, Dearani JA, et al. Impact of left ventricular systolic function on outcome of correction of chronic severe aortic valve regurgitation: implications for timing of surgical intervention. Ann Thorac Surg. 2017;103(4):1222\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"1324_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007131","volume":"11","author":"S Herrmann","year":"2018","unstructured":"Herrmann S, Fries B, Salinger T, Liu D, Hu K, Gensler D, et al. Myocardial fibrosis predicts 10-year survival in patients undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2018;11(8):e007131.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"21","key":"1324_CR13","first-page":"2502","volume":"17","author":"A Maznyczka","year":"2024","unstructured":"Maznyczka A, Prendergast B, Dweck M, Windecker S, G\u00e9n\u00e9reux P, Hildick-Smith D, et al. Timing of aortic valve intervention in the management of aortic stenosis. JACC: Cardiovasc Interventions. 2024;17(21):2502\u201314.","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"3","key":"1324_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/heartjnl-2019-314856","volume":"106","author":"JR Arnold","year":"2020","unstructured":"Arnold JR, McCann GP. Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist. Heart. 2020;106(3):174\u201381.","journal-title":"Heart"},{"issue":"5","key":"1324_CR15","volume":"8","author":"L Li","year":"2024","unstructured":"Li L, Gao J, Liu X, Chen BX, Su P, Xie B. Tissue-level evidence of fibroblast activation protein inhibitor imaging in hypertrophic obstructive cardiomyopathy: a case series. Eur Heart J. 2024;8(5):ytae189.","journal-title":"Eur Heart J"},{"issue":"1","key":"1324_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the European association for cardiovascular imaging (EACVI). J Cardiovasc Magn Reson. 2017;19(1):75.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1324_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072649","author":"M von Stumm","year":"2023","unstructured":"von Stumm M, Petersen J, Sinn M, Holst T, Sequeira-Gross TM, Muller L, et al. Correlation of myocardial native T1 and left ventricular reverse remodeling after valvular surgery. J Clin Med. 2023. . https:\/\/doi.org\/10.3390\/jcm12072649","journal-title":"J Clin Med"},{"key":"1324_CR18","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2024.02.006","author":"T Higuchi","year":"2024","unstructured":"Higuchi T, Serfling SE, Leistner DM, Speer T, Werner RA. FAPI-PET in cardiovascular disease. Semin Nucl Med. 2024. https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.02.006.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"1324_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00259-022-05994-4","volume":"50","author":"W Song","year":"2023","unstructured":"Song W, Zhang X, He S, Gai Y, Qin C, Hu F, et al. (68)Ga-FAPI PET visualize heart failure: from mechanism to clinic. Eur J Nucl Med Mol Imaging. 2023;50(2):475\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1324_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jcmg.2024.04.003","volume":"17","author":"S Settelmeier","year":"2024","unstructured":"Settelmeier S, Kessler L, Varasteh Z, Mahabadi AA, Michel L, Papathanasiou M, et al. FAPI PET imaging supports clinical decision making in academic cardiology practice: A pictorial imaging vignette. JACC Cardiovasc Imaging. 2024;17(7):811\u201323.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"1324_CR21","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221052","volume":"306","author":"L Wang","year":"2023","unstructured":"Wang L, Wang Y, Wang J, Xiao M, Xi XY, Chen BX, et al. Myocardial activity at (18)F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy. Radiology. 2023;306(2):e221052.","journal-title":"Radiology"},{"issue":"8","key":"1324_CR22","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","volume":"49","author":"B Xie","year":"2022","unstructured":"Xie B, Wang J, Xi XY, Guo X, Chen BX, Li L, et al. Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2022;49(8):2786\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1324_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12350-020-02315-w","volume":"29","author":"X Shi","year":"2022","unstructured":"Shi X, Lin X, Huo L, Li X. Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography. J Nucl Cardiol. 2022;29(2):881\u20134.","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"1324_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2967\/jnumed.122.265147","volume":"64","author":"J Diekmann","year":"2023","unstructured":"Diekmann J, Neuser J, Rohrich M, Derlin T, Zwadlo C, Koenig T, et al. Molecular imaging of myocardial fibroblast activation in patients with advanced aortic stenosis before transcatheter aortic valve replacement: a pilot study. J Nucl Med. 2023;64(8):1279\u201386.","journal-title":"J Nucl Med"},{"issue":"5","key":"1324_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/RLU.0000000000005689","volume":"50","author":"L Glantschnig","year":"2025","unstructured":"Glantschnig L, Reitsam NG, Kircher Md M, Segmiller D, Lapa C, Dierks A. Intense FAP expression of ovarian metastatic breast cancer detected by [ 68 Ga]RTX-1363 PET\/CT. Clin Nucl Med. 2025;50(5):444\u20135.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"1324_CR26","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1002\/mp.13576","volume":"46","author":"T Pan","year":"2019","unstructured":"Pan T, Einstein SA, Kappadath SC, Grogg KS, Lois Gomez C, Alessio AM, et al. Performance evaluation of the 5-Ring GE discovery MI PET\/CT system using the National electrical manufacturers association NU 2-2012 standard. Med Phys. 2019;46(7):3025\u201333.","journal-title":"Med Phys"},{"issue":"9","key":"1324_CR27","first-page":"1679","volume":"40","author":"R El-Andari","year":"2024","unstructured":"El-Andari R, Watkins AR, Fialka NM, Kang JJH, Bozso SJ, Hassanabad AF, et al. Minimally invasive approaches to mitral valve surgery: where are we now? A narrative review. Can J Cardiol. 2024;40(9):1679\u201389.","journal-title":"Can J Cardiol"},{"key":"1324_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf020","author":"F Zito","year":"2025","unstructured":"Zito F, Veen KM, Melina G, Lansac E, Schafers HJ, de Kerchove L, et al. Aortic valve repair in adults: long-term clinical outcomes and echocardiographic evolution in different valve repair techniques. Eur J Cardiothorac Surg. 2025. https:\/\/doi.org\/10.1093\/ejcts\/ezaf020.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"24","key":"1324_CR29","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1093\/eurheartj\/ehaf116","volume":"46","author":"P Unger","year":"2025","unstructured":"Unger P, Galloo X, Pibarot P. Mixed valvular heart disease: diagnosis and management. Eur Heart J. 2025;46(24):2261\u201374.","journal-title":"Eur Heart J"},{"issue":"6","key":"1324_CR30","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.jtcvs.2014.07.029","volume":"148","author":"E Quintana","year":"2014","unstructured":"Quintana E, Suri RM, Thalji NM, Daly RC, Dearani JA, Burkhart HM, et al. Left ventricular dysfunction after mitral valve repair\u2013the fallacy of normal preoperative myocardial function. J Thorac Cardiovasc Surg. 2014;148(6):2752\u201360.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1324_CR31","doi-asserted-by":"crossref","unstructured":"Alashi A, Khullar T, Mentias A, Gillinov AM, Roselli EE, Svensson LG et al. Long-Term Outcomes After Aortic Valve Surgery in Patients With Asymptomatic Chronic Aortic Regurgitation and Preserved LVEF: Impact of Baseline and Follow-Up Global Longitudinal Strain. JACC: Cardiovascular Imaging. 2020;13(1, Part 1):12\u201321.","DOI":"10.1016\/j.jcmg.2018.12.021"},{"issue":"8","key":"1324_CR32","first-page":"1342","volume":"46","author":"U Nestle","year":"2005","unstructured":"Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, R\u00fcbe C, et al. Comparison of different methods for delineation of 18F-FDG PET-Positive tissue for target volume definition in radiotherapy of patients with Non-Small cell lung cancer. J Nucl Med. 2005;46(8):1342\u20138.","journal-title":"J Nucl Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01324-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:27:42Z","timestamp":1781645262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01324-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01324-5","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and with national regulations and was approved by the local institutional review board (review board of the Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany) on 06 September 2024 (permit number 24\u20130731).\u00a0Informed consent was obtained from all subjects reported in the study prior to the imaging and therapeutic procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CL reports prior consulting activities for Blue Earth Diagnostics Ltd. (BED, Oxford, UK) and Novartis (N\u00fcrnberg, Germany). RAB is a consultant for and has received speaker\u00b4s honoraria from Bayer Healthcare (Leverkusen, Germany), Novartis (N\u00fcrnberg, Germany) and Eisai GmbH (Frankfurt, Germany) and has received travel expenses from Blue Earth Diagnostics Ltd. (BED, Oxford, UK). No other potential conflicts of interest relevant to this article exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}